As the calendar turns to 2025, it’s natural for individuals and organizations alike to reflect on the year gone by in preparation of the year to come. For us at Delphic Research, 2024 has been nothing short of phenomenal. Our team and our proprietary knowledge platform, Argus, have achieved significant milestones that underscore the impact we’re making in the world of government affairs and policy intelligence.
In addition to the thousands of print, broadcast, and podcast sources we monitor via our media monitoring partnerships, we have expanded our compendium of government, agency, and stakeholder sources monitored daily to over 850 unique sources where information of relevance might emerge.
At the end of this year, Delphic Research has now written an extraordinary 37,957 individual stories or story modules—each one representing a valuable piece of actionable intelligence. These stories were meticulously curated from a staggering 294,309 unique and subscriber-relevant information points that we pulled into our platform, allowing us to turn raw information into insights.
What sets us apart is our ability to uncover and report stories that others often overlook. Many of these are too niche for traditional media or even trade publications, yet they are vital to our customers. This focus is where Delphic Research truly shines—delivering insights that matter.
In 2024, we broke several important stories, often being the first—and in some cases, the only—source to report them. Here are just a few highlights:
•The surprise resignation of Doug Clark as CEO of the Pan-Canadian Pharmaceutical Alliance (PCPA) after a short tenure, followed by Dominic Tan’s appointment as interim CEO and Clifford Lo’s official role as acting deputy CEO. As of now, both the CEO and deputy CEO positions remain unfilled permanently.
•Unique coverage of the Ontario government’s “hard pivot” to the Life Sciences, including reporting remarks made (at multiple events through the year) by Ontario Premier Doug Ford and by Vic Fedeli, Ontario’s Minister of Economic Development and Trade and a champion of the sector within the Ontario government.
•Comprehensive coverage of the National Pharmacare legislation, from its passage through the House to the Senate and its royal assent. We detailed the unexpected twists and turns between both the legislative initiative and the government’s implementation. In the end, where the government ended up was far removed from the vision laid out in the legislation. What was once seen as a pathway to a universal, comprehensive, national/federal program (with a focus on rare diseases) ended up as a very narrow program, neither universal nor comprehensive, and focused on diabetes medications and contraceptives. Moreover, what was once assumed to be a federal, go-it-alone, approach, the legislation that was passed has now been positioned as the foundation for bilateral agreements with each Canadian province.
•The official transition of the Canadian Agency for Drugs and Technologies in Health (CADTH) into Canada’s Drug Agency (CDA), marking a significant shift in the country’s pharmaceutical landscape positioning the CDA as a vital instrument for national pharmacare.
2024 was also a year of remarkable growth for Delphic Research. We tripled our subscriber base, maintaining our focus on the health and life sciences sector while laying the groundwork to expand into new areas. As we move into 2025, we’re excited to support other parts of the healthcare system and explore additional sectors where our insights can drive meaningful change.
We also look forward to continuing as a contributor to the landscape our subscribers work in, helping to convene a more robust community within government affairs and, in particular, within Canada’s vibrant life sciences sector. We were not only proud to support the work of Life Sciences Ontario, Innovative Medicines Canada, and MedTech Canada in 2024, we also attended, presented, or organized 22 different events for the community. On top of that, we published two dozen “insight” articles on relevant topics during the year.
As we reflect on the accomplishments of 2024, we’re reminded of our mission: to elevate government affairs through knowledge. With each passing year, we grow stronger, more innovative, and more impactful. We look forward to continuing this momentum into 2025, building on the successes of the past year to reach even greater heights.
I also want to take a moment to thank our incredible team—the people who made these accomplishments possible. 2024 was not an easy year. Inventing an entirely new product category for the sector is no small task; it requires creativity, resilience, and determination. We’ve often had to make it up as we went along—this is what innovation demands—but our team rose to the challenge.
While not everyone who contributed in 2024 will continue with us in 2025, I want to express my deepest gratitude to each and every team member for their efforts. Their work has laid the foundation for the successes we’ve achieved and the bright future ahead.
As we enter 2025, I feel truly great about where we are. We have big plans, and I couldn’t be more excited about what’s in store for Delphic Research and for our customers in the year ahead.
.jpeg)
.jpeg)
